Efficacy and Safety of SHR0302 in Patients With Relapsed/Refractory Peripheral T/NK Cell Lymphoma

Clinical trial NCT05900089 · UNKNOWN

Trial details

NCT number: NCT05900089
Sponsor: Henan Cancer Hospital
Status: UNKNOWN
Phase: Phase 1
Study type: INTERVENTIONAL

Peripheral T Cell Lymphoma

Start date: 2023-05-30
Primary completion: 2025-11-01
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.